Copyright © 2015 American Chemical Society
 

June 29, 2015 Issue

Volume 93, Issue 26
09326-cover-openercxd
June 29, 2015 Issue, Vol. 93 | Iss. 26
Instrumentation and pharmaceutical firms go down the road together to develop diagnostic and drug combinations
By Ann M. Thayer
(pp. 10-13)
Features
Government & Policy
Biotechnology: Scientists and lawmakers are anxious about altered genomes (pp. 20-21)
Science & Technology
NASA’s insect-shedding surfaces reduce drag by keeping plane wings cleaner in flight (pp. 25-26)
Back Issues
 

News of the Week

DuPont Spin-off Chemours Is Ready To Launch

New company is already a market leader in titanium dioxide, fluorochemicals but faces early headwinds
(p.5)

House Passes Bipartisan Chemicals Regulation Reform Bill

Congress: Legislation would modernize 1976 Toxic Substances Control Act
(p.6)

Key Enzyme Poppies Use To Synthesize Morphine Identified

Plant Biology: Fusion protein paves way to making opioids in microbes
(p.6)

International Agency Deems 2,4-D A Possible Human Carcinogen

Pesticides: Chemical makers dispute the categorization for widely used herbicide
(p.7)

Researchers Mine Genetic Variations In People To Find New Pain Target

Drug Development: Inhibiting an enzyme relieves nerve and inflammatory pain in mice
(p.7)

Lego To Replace Oil-Based Plastics



Environment: Danish toy maker will invest $150 million, hire more than 100 people to develop sustainable plastics for its signature product
(p.8)

Modified DNA Base 5-Formylcytosine Has A Specific Biological Role

Epigenetics: The decorated cytosine isn’t just an intermediate in the body, study shows
(p.8)

Merck Scientist Arrested And Jailed On Drug Charges

Drug Trafficking: Chemical engineer is charged with making party drug at home
(p.9)

Physician Groups Question Cancer Drugs’ Values



Pharmaceuticals: Costs, risks, and benefits of cancer drugs come under renewed scrutiny

(p.9)
 

Departments

09326-bus1-Aeon1GHzcxd

Business

With Agilent gone, users fear Bruker will abuse its dominant position in the nuclear magnetic resonance market
(p.16)
Chemical maker’s non-conforming board member outlines firm’s route to sustainable chemical production
(p.18)
U.S. and U.K. firms join forces to commercialize biobased 1-butanol
(p.17)
Instrumentation and pharmaceutical firms go down the road together to develop diagnostic and drug combinations
(pp. 10-13)

Education

Yearlong research program in Dallas targets high school youths from lower socioeconomic backgrounds
(p.31)